MYOZYME alglucosidase alfa-rch 50 mg / 10 mL powder for concentrate for solution for infusion Australie - anglais - Department of Health (Therapeutic Goods Administration)

myozyme alglucosidase alfa-rch 50 mg / 10 ml powder for concentrate for solution for infusion

sanofi-aventis australia pty ltd - alglucosidase alfa, quantity: 52.5 mg - injection, powder for - excipient ingredients: monobasic sodium phosphate monohydrate; polysorbate 80; mannitol; nitrogen - myozyme (alglucosidase alfa-rch) is indicated for the long-term treatment of patients with a confirmed diagnosis of pompe disease (acid alfa-glucosidase deficiency).